Update of Rosacea · • Azelaic acid gel 15%/ 20% lotion/ cream/ foam • Benzoyl peroxide/...

Post on 23-Oct-2020

3 views 0 download

transcript

  • 15/09/2016

    1

    • Dr Samantha Eisman

    • Dermatologist Sinclair Dermatology• MBChB MRCP(UK) FCDerm(SA) FACD

    Update of Rosacea

    • Sinclair Dermatology • Professor Rod Sinclair

    Acknowledgment ‐ photographs

    • Chronic skin disorder of vascular origin• Skin of central face (convexities)• Woman• Skin type I and II

    • Prevalence 0,5%‐22%• 1,78 Million in Australia• Low self esteem

    Rosacea‐ definition

  • 15/09/2016

    2

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    ROSACEA

    Clinical Signs

    Increased vascularity

    InflammationAround vessels

    ROSACEA Disrupts barrier/ papules/ pustules

    Flush/ erythema/Dilated capillaries

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    genetic

    ROSACEA

  • 15/09/2016

    3

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    genetic EnvironmentalDietary triggerDrugs/Disease

    ROSACEA

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    genetic EnvironmentalDietary triggerDrugs/Disease

    infection

    ROSACEA

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    genetic EnvironmentalDietary triggerDrugs/Disease

    infection

    ROSACEA

    Dysregulation innate immunity‐increase toll‐like R‐2‐increase cathelicidin‐Increase kallikrein 5‐increase MMP

  • 15/09/2016

    4

    • Primary Features‐ one or more in central face

    • Flushing• Non transient erythema• Papules and pustules (no comedones)• Telangiectasia

    Diagnostic Criteria

    • Secondary Features‐ one/more may be present

    • Burning/ stinging/dryness/scaling• Red plaques/phymatous changes/oedema• Eyes signs• Peripheral location

    Diagnostic Criteria

    • 1. Erythematotelangiectatic (12%)

    • 2. Papulopustular (69%)

    • 3. Phymatous (3,7%)

    • 4. Ocular (6‐50%)

    • 5. Variants 

    Subtypes

  • 15/09/2016

    5

    • Flushing• Persistent central facial erythema (spare periocular)• Burning and stinging• Irritation from topical substances• Minimal inflammatory lesions/scale

    1. Erythematotelangiectatic (ETT)

    • Redness central face• Telangiectasia• Spare periocular skin• Papules and pustules (transient)• Oedema may be present• Flushing (mild)

    2. Papulopustular

    • Sebaceous hyperplasia• Skin thickens• Irregular surfaces and nodularities/ prominent pores• Nose/chin/forehead/eyelids

    3. Phymatous

    rhynophyma

    gnatophymametophyma

  • 15/09/2016

    6

    • May precede skin signs• 50‐70% patients• Unilateral or asymmetrical • Decrease tear secretion and Meibomian gland dysfunction• 20% present eyes first/ 50% present skin first

    4. Ocular/ Eye involvement

    injection

    • More than 1• Burning/ blurred vision/ stinging/ itching/ light sensitivity/ 

    FB/watery/ bloodshot/ dryness/telangiectasia conjunctiva or lid/ lid and periocular erythema

    • Conjunctivitis• Blepharitis• Stye (chalazion)• Meibomian gland inflammation• Rosacea keratitis (5%)‐ corneal involvement

    4. Ocular/ Eye involvement

    • Granulomatous• Chronic Lymphoedema• Steroid induced• Rosacea fulminans

    5. Variants

    lymphoedema

    Steroid induced

    Rosacea fulminans

    granulomatous

  • 15/09/2016

    7

    • Acne• Perioral dermatitis• Keratosis Pilaris• Seborrhoeic dermatitis• Photodermatitis (seasonal/ extrafacial)• Contact dermatitis (scale/ eczematous/ site application)• Systemic Lupus erythematosis (malar/ photosensitivity)• DLE (follicular plug/ scale /pigmentary changes/ scar)• Sarcoidosis (no skin surface changes/ smooth)• Tinea facei

    Differential diagnosis

    • Comedones• Not limited face• Younger age onset• No telangiectasia or flushing

    • Both‐ papules/ pustules/ erythema

    Acne

  • 15/09/2016

    8

    • monomorphic papules• Around orifices• Smaller lesions• No telangiectasia/ flush/blush

    Peri‐oral dermatitis

    • Fixed erythema• Small follicular keratotic plugs• Arms and thighs• Younger patient

    Keratosis pilaris

    • Eczematous• Greasy scale in scalp and brow/ earparanasal/nasolabial/ extrafacial

    • Often co‐ exist

    • Both‐ erythema/ blepharitis

    Seborrhoeic dermatitis

  • 15/09/2016

    9

    • Avoid trigger• Skin care• Disease specific• Maintenance

    Treatment of Rosacea

    • Avoid trigger• Skin care• Disease specific• Maintenance

    Treatment

    • Heat (exercise/ bath/ food/ clothes/ heating home)• Exertion• Emotions (anger/ embarrassment/ stress)• Weather (wind/ heat)• Food (pepper/ coffee/ tea/ citrus/ tomato/choc)• Topical products (cosmetics/ toners/anti‐wrinkle/acne/fragrance)• Drugs (vasodilators/ steroids/ tamoxifen/ erectile dysfunction/ 

    metformin/ nicotinic acid)

    Treatment‐ avoid trigger

  • 15/09/2016

    10

    • Avoid trigger• Skin care• Disease specific• Maintenance

    Treatment

    • Soap Free washes

    • Simple emollients (apply after medicated products)

    • Sun protection (UVA and UVB)‐ at least SPF 30

    • Cosmetics

    Treatment‐ Skin care

    • Avoid trigger• Skin care• Disease specific• Maintenance

    Treatment

  • 15/09/2016

    11

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    ROSACEA

    Treatment of inflammatory component‐Papulopustular

    (papules/ pustules/ phymatous)

    • Topical• Antibiotics• Anti‐inflammatory

    • Systemic (extensive or non‐ responsive)• Antibiotics (off‐label use)• Isotretinoin (off‐label)• ivermectin

    • Laser/ Surgery

    • Metronidazole 0,5%/ 1%/0,75% / cream/gel/ointment/ lotion

    • Erythromycin gel

    • Clindamycin lotion 

    Topical antibiotics

  • 15/09/2016

    12

    • Azelaic acid gel 15%/ 20% lotion/ cream/ foam

    • Benzoyl peroxide/ +/‐ clindamycin or erythromycin

    • Retinoids (adapalene cream/gel and tretinoin cream/gel)

    • Calcineurin inhibitors (pimecrolimus and tacrolimus)

    • Sulphacetamide 10%/ sulphur 5% lotion/ cream

    • Ivermectin 1% cream / permethrin 5% cream

    Topical anti‐inflammatory

    • First line antibiotics• Doxycycline/ minocycline 50‐100mg daily

    • Second line antibiotics• Erythromycin 250mg‐500mg BD/QDS or 400mg BD• Clarithromycin 250mg‐500mg BD/QDS• Azithromycin 250mg 3weekly/ 1000mg 45 days then 500mg 45 

    days)• Amoxycillin• Bactrim• Metronidazole 200mg BD 6 weeks

    • Isotretinoin‐ low dose/ longterm• Ivermectin

    Systemic treatment

    Pathogenesis

    Increased vascularity

    InflammationAround vessels

    ROSACEA

  • 15/09/2016

    13

    Treatment of Vascular Component‐Erythematotelangiectatic

    Redness/ telangiectasia/ flushing

    Topical vasoconstrictorsSystemicLaser Surgery  

    • Brimonidine 0,5% gel

    • Oxymetazoline 0.05% solution (nasal)

    • ‐

    Topical vasoconstrictors

    • B blockers• Clonidine• Aspirin • Naloxone• Ondansetron• SSRIs• Contraceptive pill• Amitriptyline

    • Botox 

    Systemic treatment for flushing

  • 15/09/2016

    14

    • Telangiectasia/ persisting erythema AND symptoms

    • Short wavelength Lasers (superficial vessels and persistent erythema)• Pulsed dye laser/ long pulsed dye laser• Long‐pulse KTP laser

    • IPL

    • Diathermy

    Laser/Surgery

    • Artificial tears• Eyelid hygiene• Warm compress and massage• Cyclosporine 2% drops/ 0,05% emulsion• Metronidazole eye drops (compounded)• !0% sulphacetamide eye drops • Azithromycin 1,5% drops• Azithromycin and other oral antibiotics

    • Ophthalmology review

    Treatment Eyes

    • High quality evidence• Topical azelaic acid/ ivermectin/ brimonidine• Doxy/ isotretinoin

    • Moderate quality evidence• Topical metronidazole• Oral tetracyclines

    • Low quality evidence• Low dose minocycline (45mg)• IPL AND laser• Cyclosporine ophthalmic emulsion

    Cochrane review 2015

  • 15/09/2016

    15

    • Topical serine protease inhibitors/? Cathelicidin blockers

    • Topical mast cell stabilisers (cromolyn sodium)

    • Nitric oxide inhibitors ( vasoconstrictors)

    Future Treatments

    • 45 year old woman• C/O 1 year flushing when eats spicy food or drinks red wine• Metronidazole burns• Azelaic acid too drying• Doxy and minocycline 8 weeks each• Uses thick make up to conceal• Many cosmetics sting/ burn

    Case 1 

    • Lifestyle modification• Skin care ( emollient/ sunscreen/ soap free wash/ avoid 

    toners/ mineral make up)

    • Combination• Topical anti‐inflammatory/antibiotic

    • pimecrolimus/ azelaic acid/ metronidazole• Topical  vasoconstrictor

    • Brimonidine® gel• Oral antibiotic‐ doxy 100mg daily 3/12 (if inflammatory)• Laser/ light ( decrease recurrence after ab)

    ETT rosacea

  • 15/09/2016

    16

    • Reduces moderate to severe erythema• 5 DBPCT confirm effectiveness• TGA 2014

    • Onset action 30 min• Lasts 12 hr• SE‐mild and transient worsening erythema/flushing• Expensive

    Brimonidine® gel

    • Lifestyle modification• Skin care ( emollient/ sunscreen/ soap free wash/ avoid 

    toners/ mineral make up)

    • Combination• Topical anti‐inflammatory/antibiotic

    • pimecrolimus/ azelaic acid/ metronidazole• Topical  vasoconstrictor

    • Brimonidine® gel• Oral antibiotic‐ doxy 100mg daily 3/12 (if inflammatory)• Laser/ light ( decrease recurrence after ab)

    ETT rosacea

    Pulsed dye laser

  • 15/09/2016

    17

    • 68 year old man• Red face• No ETOH• Good skin care• Tried many topicals• Tried Doxy• Tried Laser 

    Case 2

    • Environmental/ trigger factors• Skin Care• Combination

    • Topical anti‐inflammatory‐ azelaic acid/ pimecrolimus• Topical antibiotic‐ metronidazole• Topical Ivermectin

    • Oral antibiotics

    • Isotretinoin (referral)

    • Maintenance• Taper antibiotics• Topicals 6‐9 months

    Papulopustular rosacea

  • 15/09/2016

    18

    • Anti‐parasite and anti‐inflammatory• FDA 2014/ TGA 2015• Inflammatory lesions (mod‐severe PPR rosacea)• Once daily• Superior to vehicle in two DBRCT• 38‐40% clear after 12 weeks (cf 12‐19% vehicle)• Burning 

  • 15/09/2016

    19

    • As for papulopustular rosacea

    • Isotretinoin ( before and or after laser)

    • Ablative lasers‐ CO2 and erbium;YAG

    • Surgery/ Electrosurgery/ dermabrasion / cryosurgery

    • Psyche

    Rhynophyma

    • Non contagious inflammation of skin of face

    • Cause unknown but many new theories (therapeutic targets)

    • No cure but options for control

    • Avoid triggers and good skin care

    • Variety of topicals/ medications and laser‐ subtype

    • Non responders/ eye disease – referral

    • Online support groups 

    Take home